Brimonidine Tartrate 0.25% / Ivermectin 1% / Metronidazole 1% / Niacinamide 4%
Product Images NDC 72934-1028

3 FDA label images from Sincerus Florida, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate 0.25% / Ivermectin 1% / Metronidazole 1% / Niacinamide 4% (NDC 72934-1028). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zx (2 End)

Zx (2 End)
The image shows a white cylindrical container with a label that includes usage directions and contact information for Sincerus Florida, LLC. The label advises applying the product topically, washing hands after use, and storing it at controlled room temperature (20-25°C). The label also provides a phone number and a website for reporting adverse reactions. The product name and active ingredient details are not visible on this label.*
FDA Label Image

C (1028 2 Front)

C (1028 2 Front)
BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% topical gel in a white cylindrical container. The label shows the NDC 72934-1028-2 and identifies the product as a compounded drug. The label also includes the Sincerus Florida, LLC logo and states the product is made in the USA with a net weight of 30 grams.*
FDA Label Image

Ff (1028 2 Middle)

Ff (1028 2 Middle)
The image shows a cylindrical container label for BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% by Sincerus Florida, LLC. The label lists active ingredients with their strengths, and inactive ingredients such as Krisgel 100, Potassium Azeloyl Diglycinate, and a gel base. The label includes manufacturing (MFG: 01/01/1970) and lot details (Lot 171082ABCDEFGH01).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.